
|Videos|August 27, 2019
Update on latest clinical data for CooperVision's MiSight myopia contact lens
Author(s)Deborah Jones, BSc, FCOptom, FAAO
Advertisement
Deborah Jones, BSc, FCOptom, FAAO, provides insight into the latest clinical data on CooperVision’s MiSight 1 day myopia control lens. This lens is not yet approved in the U.S.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Ortho-k: More than meets the eye to control myopia progression
2
Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology
3
Crafting your own eyewear brand: Streamlining the private label process
4
ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA
5












































.png)


